University Of Heidelberg Medical Center

This study tests whether adding isatuximab to iberdomide maintenance therapy after a stem cell transplant can reduce cancer cells in the bone marrow more than iberdomide alone. About 411 adults with newly diagnosed multiple myeloma will take part. The goal is to see if the combin…

This study tests several new drug combinations (teclistamab, talquetamab, and JNJ-79635322) in 160 adults aged 18-70 with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The goal is to see if these combinations are safe and can improve treatment resp…